Related Experiment Video

Updated: Jul 30, 2026

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow

Y Atsuta1, R Suzuki, K Yamamoto

  • 1Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Tsurumai-cho, Showa-ku, Nagoya, Japan. y-atusta@med.nagoya-u.ac.jp

Bone Marrow Transplantation
|January 10, 2006
PubMed

Insights

This study evaluated chronic graft-versus-host disease (cGVHD) in Japanese bone marrow transplant survivors. Factors like prior acute GVHD and unrelated donors influenced cGVHD onset, but it didn't impact overall mortality.

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Chronic graft-versus-host disease (cGVHD) is a significant complication after allogeneic bone marrow transplantation.
  • Understanding incidence and prognostic factors is crucial for patient management and outcomes.

Purpose of the Study:

  • To evaluate the incidence and prognostic factors of cGVHD in Japanese patients post-bone marrow transplantation.
  • To assess the impact of cGVHD on mortality and survival.
  • To determine the need for a specific prognostic model for Japanese patients.

Main Methods:

  • Retrospective analysis of 255 Japanese patients surviving >100 days post-bone marrow transplantation.
  • Evaluation of cGVHD incidence, associated risk factors, and mortality.
  • Comparison of prognostic factors and outcomes with Western populations.

Main Results:

  • 47% of patients developed cGVHD, associated with prior acute GVHD (grade 2-4) and unrelated donors.
  • cGVHD presence did not significantly impact overall mortality (HR=0.89).
  • Infection, ongoing corticosteroid use, and low Karnofsky score (<80) predicted cGVHD-specific mortality.
  • Four-year cGVHD-specific survival was 79%.

Conclusions:

  • Japanese patients exhibited lower cGVHD severity and mortality compared to Western populations, potentially due to genetic homogeneity.
  • Existing Western prognostic models were inadequate for classifying Japanese patients.
  • A distinct prognostic model is needed to identify high-risk Japanese patients for cGVHD.

More Related Videos

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...